Document is current
Any future updates will be listed below
-
Authors
Paradis, Justine S.
Feng, Xiang http://orcid.org/0000-0002-4441-3152
Murat, Brigitte
Jefferson, Robert E. http://orcid.org/0000-0002-8641-8736
Sokrat, Badr
Szpakowska, Martyna http://orcid.org/0000-0002-5659-8377
Hogue, Mireille
Bergkamp, Nick D.
Heydenreich, Franziska M.
Smit, Martine J. http://orcid.org/0000-0003-2713-0238
Chevigné, Andy http://orcid.org/0000-0003-4768-6743
Bouvier, Michel http://orcid.org/0000-0003-1128-0100
Barth, Patrick http://orcid.org/0000-0002-0744-6844
- License Information
-
More Information
Article History
Received: 16 March 2022
Accepted: 24 October 2022
First Online: 11 November 2022
Competing interests
: M.B. is the president of the scientific advisory Board of Domain Therapeutics, which licensed some of the BRET-based biosensors used in the present study for their commercial use. P.B. holds patents and provisional patent applications in the field of engineered T-cell therapies and protein design. The other authors declare no competing interests.
